BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 11974460)

  • 1. [Differentiated thyroid carcinoma. Surgery and significance of lymph node involvement].
    Gemsenjäger E; Heitz PU; Martina B; Schweizer I
    Chirurg; 2002 Jan; 73(1):38-43; discussion 43-5. PubMed ID: 11974460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differentiated thyroid carcinoma. Follow-up of 264 patients from one institution for up to 25 years.
    Gemsenjäger E; Heitz PU; Seifert B; Martina B; Schweizer I
    Swiss Med Wkly; 2001 Mar; 131(11-12):157-63. PubMed ID: 11416889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Therapy concept in differentiated thyroid gland carcinoma--results of 25 years with 257 patients].
    Gemsenjäger E; Heitz PU; Martina B; Schweizer I
    Praxis (Bern 1994); 2000 Nov; 89(44):1779-97. PubMed ID: 11109916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Which lymphadenectomy in papillary thyroid gland carcinoma?].
    Schweizer I; Seifert B; Gemsenjäger E
    Swiss Surg; 2003; 9(2):63-8. PubMed ID: 12723285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic variables of papillary and follicular thyroid carcinoma patients with lymph node metastases and without distant metastases.
    Lin JD; Liou MJ; Chao TC; Weng HF; Ho YS
    Endocr Relat Cancer; 1999 Mar; 6(1):109-15. PubMed ID: 10732793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Therapeutic concepts and long-term outcome in thyroid gland carcinoma].
    Linder R; Fuhrmann J; Hammerschmidt D
    Zentralbl Chir; 1996; 121(6):459-64. PubMed ID: 8767331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prospective therapy study in differentiated thyroid carcinoma].
    Gemsenjäger E; Heitz P; Martina B
    Schweiz Med Wochenschr; 1995 Nov; 125(46):2226-36. PubMed ID: 8525342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of Survival Outcomes Following Postsurgical Radioactive Iodine Versus External Beam Radiation in Stage IV Differentiated Thyroid Carcinoma.
    Yang Z; Flores J; Katz S; Nathan CA; Mehta V
    Thyroid; 2017 Jul; 27(7):944-952. PubMed ID: 28446057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of recurrence in a homogeneously managed pT3-differentiated thyroid carcinoma population.
    Chereau N; Dauzier E; Godiris-Petit G; Noullet S; Brocheriou I; Leenhardt L; Buffet C; Menegaux F
    Langenbecks Arch Surg; 2018 May; 403(3):325-332. PubMed ID: 29445865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival of differentiated thyroid carcinoma studied in 500 patients.
    Lerch H; Schober O; Kuwert T; Saur HB
    J Clin Oncol; 1997 May; 15(5):2067-75. PubMed ID: 9164219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Indication and extent of cervical lymph node dissection in differentiated thyroid carcinoma].
    Kayser C; Tittelbach-Helmrich D; Meyer S; Thomusch O
    Zentralbl Chir; 2011 Aug; 136(4):364-73. PubMed ID: 20711956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of surgery, radioiodine, and external radiation therapy on the clinical outcome of patients with differentiated thyroid carcinoma.
    Tsang RW; Brierley JD; Simpson WJ; Panzarella T; Gospodarowicz MK; Sutcliffe SB
    Cancer; 1998 Jan; 82(2):375-88. PubMed ID: 9445196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differentiated thyroid carcinoma in childhood and adolescence-clinical course and role of radioiodine.
    Chow SM; Law SC; Mendenhall WM; Au SK; Yau S; Mang O; Lau WH
    Pediatr Blood Cancer; 2004 Feb; 42(2):176-83. PubMed ID: 14752883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathological tumor-node-metastasis (pTNM) staging for papillary and follicular thyroid carcinomas: a retrospective analysis of 700 patients.
    Loh KC; Greenspan FS; Gee L; Miller TR; Yeo PP
    J Clin Endocrinol Metab; 1997 Nov; 82(11):3553-62. PubMed ID: 9360506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Lymph node dissection in non-medullary differentiated thyroid carcinoma].
    Mathonnet M
    Ann Chir; 2006; 131(6-7):361-8. PubMed ID: 16329987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of differentiated thyroid carcinomas.
    Fernández-Vañes L; Llorente JL; García-Cabo P; Menéndez M; Pedregal D; Rodrigo JP; López F
    Acta Otorrinolaringol Esp (Engl Ed); 2019; 70(4):200-206. PubMed ID: 29880224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymph node dissection in patients with differentiated thyroid carcinoma--who benefits?
    Mann B; Buhr HJ
    Langenbecks Arch Surg; 1998 Oct; 383(5):355-8. PubMed ID: 9860231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differentiated thyroid cancer. Impact of adjuvant external radiotherapy in patients with perithyroidal tumor infiltration (stage pT4).
    Farahati J; Reiners C; Stuschke M; Müller SP; Stüben G; Sauerwein W; Sack H
    Cancer; 1996 Jan; 77(1):172-80. PubMed ID: 8630926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Lymph node dissection in papillary and follicular thyroid cancer].
    Vorländer C; Lienenlüke RH; Wahl RA
    Chirurg; 2008 Jun; 79(6):564-70. PubMed ID: 18317715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High recurrent rate of multicentric papillary thyroid carcinoma.
    Lin JD; Chao TC; Hsueh C; Kuo SF
    Ann Surg Oncol; 2009 Sep; 16(9):2609-16. PubMed ID: 19533244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.